Characterization and modulation of the transferrin receptor on brain capillary endothelial cells

Pharmaceutical Research

Volumn 21, Issue 5, 2004, Pages 761-769

  Visser, Corine C ^a   Voorwinden, L Heleen ^a   Crommelin, Daan J A ^b   Danhof, Meindert ^a   De Boer, Albertus G ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Astrocytic factors; Deferoxamine; Drug targeting; In vitro blood brain barrier; Iron; Lipopolysaccharide; Modulation; N acetyl L cysteine; Receptor mediated endocytosis; Tyrphostin A8

Indexed keywords

ACETYLCYSTEINE; CELL PROTEIN; DEFEROXAMINE MESYLATE; IODINE 125; IRON; LIPOPOLYSACCHARIDE; TRANSFERRIN RECEPTOR; TYRPHOSTIN;

ANIMAL CELL; ARTICLE; BRAIN CAPILLARY; CELL CULTURE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOTHELIUM CELL; MODULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR OCCUPANCY; STATISTICAL SIGNIFICANCE; VASCULAR ENDOTHELIUM;

ACETYLCYSTEINE; ANIMALS; ASTROCYTES; CAPILLARIES; CATTLE; CELLS, CULTURED; CEREBROVASCULAR CIRCULATION; DEFEROXAMINE; DOWN-REGULATION; ENDOCYTOSIS; ENDOTHELIAL CELLS; EXTRACELLULAR SPACE; FREE RADICAL SCAVENGERS; INFLAMMATION; IRON; LIPOPOLYSACCHARIDES; RECEPTORS, TRANSFERRIN; TRANSFERRIN; TYRPHOSTINS;

EID: 3042836954     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000026425.69874.8e     Document Type: Article

References (36)

1. L. L. Rubin and J. M. Staddon. The cell biology of the blood-brain barrier. Annu. Rev. Neurosci. 22:11-28 (1999).
2. W. M. Pardridge. Blood-brain barrier biology and methodology. J. Neurovirol. 5:556-569 (1999).
3. W. M. Pardridge. Drug delivery to the brain. J. Cereb. Blood Flow Metab. 17:713-731 (1997).
4. A. G. de Boer, I. C. van der Sandt, and P. J. Gaillard. The role of drug transporters at the blood-brain barrier. Annu. Rev. Pharmacol. Toxicol. 43:629-656 (2003).
5. W. Pardridge. Drug targeting, drug discovery, and brain drug development, Brain Drug Targeting: The Future of Brain Drug Development, Press Syndicate of the University of Cambridge, Cambridge, 2001, pp. 1-12.
6. K. R. Duffy and W. M. Pardridge. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Res. 420:32-38 (1987).
7. B. Dehouck, L. Fenart, M. P. Dehouck, A. Pierce, G. Torpier, and R. Cecchelli. A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier. J. Cell Biol. 138:877-889 (1997).
8. H. E. de Vries, B. Breedveld, J. Kuiper, A. G. de Boer, T. J. Van Berkel, and D. D. Breimer. High-density lipoprotein and cerebral endothelial cells in vitro: interactions and transport. Biochem. Pharmacol. 50:271-273 (1995).
9. N. Shi, Y. Zhang, C. Zhu, R. J. Boado, and W. M. Pardridge. Brain-specific expression of an exogenous gene after i.v. administration. Proc. Natl. Acad. Sci. USA 98:12754-12759 (2001).
10. T. Moos and E. H. Morgan. Transferrin and transferrin receptor function in brain barrier systems. Cell. Mol. Neurobiol. 20:77-95 (2000).
11. E. Baker and E. H. Morgan. Iron Transport. In J. H. Brock, J. W. Halliday, M. Pippard, and L. W. Powell (eds.), Iron Metabolism in Health and Disease, Saunders, London, 1994, pp. 63-95.
12. D. Trinder and E. Baker. Transferrin receptor 2: a new molecule in iron metabolism. Int. J. Biochem. Cell Biol. 35:292-296 (2003).
13. P. J. Gaillard, L. H. Voorwinden, J. L. Nielsen, A. Ivanov, R. Atsumi, H. Engman, C. Ringbom, A. G. de Boer, and D. D. Breimer. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur. J. Pharm. Sci. 12:215-222 (2001).
14. H. M. Nguyen, C. M. Cahill, P. S. McPherson, and A. Beaudet. Receptor-mediated internalization of [3H]-neurotensin in synaptosomal preparations from rat neostriatum. Neuropharm. 42:1089-1098 (2002).
15. M. Gumbleton, A. G. Abulrob, and L. Campbell. Caveolae: an alternative membrane transport compartment. Pharm. Res. 17:1035-1048 (2000).
16. J. L. Casey, D. M. Koeller, V. C. Ramin, R. D. Klausner, and J. B. Harford. Iron regulation of transferrin receptor mRNA levels requires iron- responsive elements and a rapid turnover determinant in the 3′ untranslated region of the mRNA. EMBO J. 8:3693-3699 (1989).
17. L. C. Kuhn. mRNA-protein interactions regulate critical pathways in cellular iron metabolism. Br. J. Haematol. 79:1-5 (1991).
18. W. van Gelder, M. I. Huijskes-Heins, M. I. Cleton-Soeteman, J. P. van Dijk, and H. G. van Eijk. Iron uptake in blood-brain barrier endothelial cells cultured in iron- depleted and iron-enriched media. J. Neurochem. 71:1134-1140 (1998).
19. K. R. Bridges and A. Cudkowicz. Effect of iron chelators on the transferrin receptor in K562 cells. J. Biol. Chem. 259:12970-12977 (1984).
20. C. Q. Xia and W. C. Shen. Tyrphostin-8 enhances transferrin receptor-mediated transcytosis in Caco-2- cells and inreases hypoglycemic effect of orally administered insulin-transferrin conjugate in diabetic rats. Pharm. Res. 18:191-195 (2001).
21. W. Malorni, U. Testa, G. Rainaldi, E. Tritarelli, and C. Peschle. Oxidative stress leads to a rapid alteration of transferrin receptor intravesicular trafficking. Exp. Cell Res. 241:102-116 (1998).
22. L. Descamps, M. P. Dehouck, G. Torpier, and R. Cecchelli. Receptor-mediated transcytosis of transferrin through blood-brain barrier endothelial cells. Am. J. Physiol. 270:H1149-H1158 (1996).
23. T. J. Raub and C. R. Newton. Recycling kinetics and transcytosis of transferrin in primary cultures of bovine brain microvessel endothelial cells. J. Cell. Physiol. 149:141-151 (1991).
24. J. A. Koenig, J. M. Edwardson, and P. P. Humphrey. Somatostatin receptors in Neuro2A neuroblastoma cells: ligand internalization. Br. J. Pharmacol. 120:52-59 (1997).
25. E. A. Rutledge, C. A. Mikoryak, and R. K. Draper. Turnover of the transferrin receptor is not influenced by removing most of the extracellular domain. J. Biol. Chem. 266:21125-21130 (1991).
26. P. J. Gaillard, A. G. de Boer, and D. D. Breimer. Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro. Microvasc. Res. 65:24-31 (2003).
27. W. van Gelder, M. I. Huijskes-Heins, J. P. van Dijk, M. I. Cleton-Soeteman, and H. G. van Eijk. Quantification of different transferrin receptor pools in primary cultures of porcine blood-brain barrier endothelial cells. J. Neurochem. 64:2708-2715 (1995).
28. R. S. Britton, K. L. Leicester, and B. R. Bacon. Iron toxicity and chelation therapy. Int. J. Hematol. 76:219-228 (2002).
29. Y. Zhang and W. M. Pardridge. Rapid efflux from brain to blood across the blood-brain barrier. J. Neurochem. 76:1597-1600 (2001).
30. M. B. Wheeler, R. W. Gelling, S. A. Hinke, B. Tu, R. A. Pederson, F. Lynn, J. Ehses, and C. H. McIntosh. Characterization of the carboxyl-terminal domain of the rat glucose- dependent insulinotropic polypeptide (GIP) receptor. A role for serines 426 and 427 in regulating the rate of internalization. J. Biol. Chem. 274:24593-24601 (1999).
31. W. M. Pardridge and J. Eisenberg, and J. Yang. Human blood-brain barrier transferrin receptor. Metabolism 36:892-895 (1987).
32. M. Wilcke and E. Walum. Characterization of leptin intracellular trafficking. Eur. J. Histochem. 44:325-334 (2000).
33. R. Hallmann, D. L. Savigni, E. H. Morgan, and E. Baker. Characterization of iron uptake from transferrin by murine endothelial cells. Endothelium 7:135-147 (2000).
34. A. G. de Boer, P. J. Gaillard, and D. D. Breimer. The transference of results between blood-brain barrier cell culture systems. Eur. J. Pharm. Sci. 8:1-4 (1999).
35. H. Baumann, and J. Gauldie. The acute phase response. Immunol. Today 15:74-80 (1994).
36. S. Kim and P. Ponka. Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J. Biol. Chem. 275:6220-6226 (2000).